ebook Munafa Stock Market Course + Intraday & FNO calls  

       

MYGN announcements Myriad Genetics, Inc. announcements and dividends declared NASDAQ

Myriad Genetics, Inc. Complete list of announcements declared & dividend announcements by Myriad Genetics, Inc. MYGN

Myriad Genetics, Inc. MYGN listed on NASDAQ and deals in Health Care Biotechnology In Vitro In Vivo Diagnostic Substances

Announcements and dividends declared by Myriad Genetics, Inc. MYGN

Wells Fargo Initiates Coverage of Myriad Genetics (MYGN) with Overweight Recommendation
Fintel reports that on August 27, 2024, Wells Fargo initiated coverage of Myriad Genetics (NasdaqGS:MYGN) with a Overweight recommendation.
Announcement as on 29 August 2024

Myriad Genetics (MYGN) Tops Q4 Earnings and Revenue Estimates
Myriad Genetics (MYGN) came out with quarterly earnings of [CO].04 per share, beating the Zacks Consensus Estimate of [CO].02 per share. This compares to loss of [CO].12 per share a year ago. These figures are adjusted for non-recurring
Announcement as on 27 February 2024

Reasons to Hold on to Myriad Genetics (MYGN) Stock for Now
Myriad Genetics, Inc. MYGN has been gaining from robust first-quarter 2022 results. Spectacular improvement in Pharmacogenomics testing revenues, along with growth in tumor profiling and GeneSight test volumes, looks encouraging. However, stiff competition
Announcement as on 26 May 2022

Here's Why You Should Retain Myriad Genetics (MYGN) for Now
Myriad Genetics, Inc. MYGN is well poised for growth in the coming quarters on the ongoing strong recovery in testing volumes. The company’s recent launches of myRisk and RiskScore raise optimism. A strong solvency position is an added advantage. However
Announcement as on 04 October 2021

Here's Why You Should Retain Myriad Genetics (MYGN) for Now
Myriad Genetics, Inc. MYGN is well poised for growth in the coming quarters on the ongoing strong recovery in testing volumes. The company’s recent launches of myRisk and RiskScore raise optimism. A strong solvency position is an added advantage. However
Announcement as on 04 October 2021

Announcements by Myriad Genetics, Inc. first page | Next page |

MYGN Myriad Genetics, Inc. current price & indicator signals

Moving Averages for Myriad Genetics, Inc.

  • 5Day Average: 7.27
  • 12Day Average: 7.25
  • 20Day Average: 6.95
  • 50Day Average: 7.43
  • 100Day Average: 6.69
  • 150Day Average: 6.13
  • 200Day Average: 6.93

MYGN Indicators & signals

Indicator MACD (12,26,9)

7.25, 7.22, -0.03
Indicator MACD is in positive zone

Indicator ADX (14)

0, 22.5, 22.5
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 50
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MYGN Myriad Genetics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
04 Thu Dec 2025 7.33 7.15 to 7.38 0% 0.56 times
03 Wed Dec 2025 7.33 7.02 to 7.35 4.42% 0.74 times
02 Tue Dec 2025 7.02 6.93 to 7.15 -0.57% 0.71 times
01 Mon Dec 2025 7.06 7.01 to 7.54 -7.47% 1 times
28 Fri Nov 2025 7.63 7.51 to 7.72 0.39% 0.34 times
26 Wed Nov 2025 7.60 7.57 to 7.89 -3.92% 2.03 times
25 Tue Nov 2025 7.91 7.71 to 8.09 2.33% 0.87 times
24 Mon Nov 2025 7.73 7.32 to 7.78 4.74% 1.06 times
21 Fri Nov 2025 7.38 6.82 to 7.49 6.96% 1.17 times
20 Thu Nov 2025 6.90 6.55 to 7.24 7.14% 1.11 times
19 Wed Nov 2025 6.44 6.43 to 6.89 -2.87% 0.97 times
18 Tue Nov 2025 6.63 6.61 to 6.87 -0.45% 0.97 times

Videos related to: MYGN announcements Myriad Genetics, Inc. announcements and dividends declared NASDAQ

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

MYGN announcements Myriad Genetics, Inc. announcements and dividends declared NASDAQ

 

Back to top